Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach

Area of Science:

• Pharmacology
• Obstetrics
• Drug Metabolism

Background:

• Medication use during pregnancy is common.
• Pregnancy significantly alters maternal physiology, impacting drug pharmacokinetics.
• Mechanistic approaches aid in predicting drug interactions and pharmacokinetic changes.

Purpose of the Study:

• To elucidate the effects of pregnancy on drug pharmacokinetics.
• To identify specific pharmacokinetic pathways affected by pregnancy.
• To inform dosage adjustments for medications used during pregnancy.

Main Methods:

• Analysis of observational studies on drug pharmacokinetics in pregnant women.
• Evaluation of changes in drug bioavailability, volume of distribution, and clearance.
• Assessment of alterations in drug metabolism by cytochrome P450 (CYP) and uridine diphosphate glucuronosyltransferase (UGT) enzymes.
• Review of renal excretion patterns of drugs during pregnancy.

Main Results:

• Drug bioavailability is generally not altered during pregnancy.
• Increased plasma volume and altered protein binding affect drug distribution.
• Elimination half-life changes due to altered volume of distribution and clearance.
• Increased renal excretion of unchanged drugs.
• Enhanced activity of CYP3A4, CYP2D6, CYP2C9, UGT1A4, and UGT2B7.
• Decreased activity of CYP1A2 and CYP2C19.
• Dosage adjustments may be needed for drugs metabolized by induced or inhibited enzymes or renally excreted.

Conclusions:

• Pregnancy-induced pharmacokinetic changes necessitate careful drug management.
• Mechanistic-based approaches can predict drug behavior during pregnancy.
• Further clinical studies are required to fully understand and manage drug pharmacokinetics in pregnancy.
• Individualized evaluation is needed for drugs with complex elimination pathways.